Industry News
New methods for analysing gene function
Newly developed methods to produce and analyse genetic mosaics are expected to allow researchers to induce multispectral genetic mosaics in vertebrate models such as mice and zebrafish. [ + ]
Challenges facing Australian biomedical research
Biomedical research in Australia faces a number of challenges. Real funding for research has been falling over time. And a cascade of issues confront the community. [ + ]
New drug holds promise for therapy-resistant breast cancer
Scientists have identified a first-in-class molecule that shuts down estrogen-sensitive breast cancer. [ + ]
Lizard venom could treat blood clots
An international research team is studying various types of lizard venom as possible treatments for blood-clotting diseases. [ + ]
Bendable batteries can be implanted in the body
Chinese researchers have engineered bendable batteries, suitable for implantation in the human body, which can run on body-inspired liquids such as a normal IV saline solution and a cell-culture medium. [ + ]
Life Sciences Queensland appoints new chairman
Industry group Life Sciences Queensland has appointed Professor Peter Andrews as its new chairman. [ + ]
LBT to trial diabetic foot ulcer prototype
LBT Innovations, an Australian-listed medical technology company, has signed an agreement with Central Adelaide Local Health Network (CALHN) Vascular and Endovascular Services to use LBT's WoundVue prototype device in a clinical trial. [ + ]
VivaGel BV trials declared a success
Starpharma has announced that its two phase 3 trials of VivaGel BV for prevention of recurrent bacterial vaginosis (rBV) achieved their primary objective, demonstrating statistically significant superiority compared to placebo in preventing rBV based on topline data. [ + ]
Novogen says Cantrixil trial progressing as planned
Novogen, an ASX-listed oncology drug development company, has announced that its phase I clinical trial of Cantrixil in ovarian cancer is progressing as planned. [ + ]
New regenerative tissue technology developed
Scientists have developed a new technology, tissue nano-transfection (TNT), that can generate any cell type of interest for treatment within a patient's own body. [ + ]
La Trobe University joins ASTech
The ARC Training Centre for Portable Analytical Separation Technologies (ASTech) has announced La Trobe University as the latest addition to its university nodes. [ + ]
US scientists correct heritable heart condition in human embryos
US scientists have used CRISPR to edit human embryos, removing a mutation linked to a heritable heart condition. [ + ]
Is workplace health and safety important to you?
If the answer is yes, then the SAFETYconnect conference and exhibition in Sydney is a must-attend event for you and your team. [ + ]
Misfolded pancreatic protein can induce symptoms of diabetes
US researchers have discovered that the symptoms of diabetes can be induced by a misfolded form of a pancreatic protein. [ + ]
IBM launches CTMS to streamline research operations
IBM's Clinical Trial Management System (CTMS) for Sites is designed to streamline the clinical trials management process and maximise operational efficiencies. [ + ]
